1085 related articles for article (PubMed ID: 17613352)
1. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
3. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
7. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
Acalovschi M
Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
[No Abstract] [Full Text] [Related]
8. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
9. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
10. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
[TBL] [Abstract][Full Text] [Related]
12. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
14. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
16. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
17. Natural history: the importance of viral load, liver damage and HCC.
Wursthorn K; Manns MP; Wedemeyer H
Best Pract Res Clin Gastroenterol; 2008; 22(6):1063-79. PubMed ID: 19187867
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hepatocellular carcinoma in Southern Iran.
Hajiani E; Masjedizadeh R; Hashemi J; Azmi M; Rajabi T
Saudi Med J; 2005 Jun; 26(6):974-7. PubMed ID: 15983686
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma development in cirrhosis.
Okuda H
Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]